Simulation-based sodium thiosulfate dosing strategies for the treatment of Calciphylaxis

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 5, 2011, Pages 1155-1159

  Singh, Rajendra Pratap ^a   Derendorf, Hartmut ^a   Ross, Edward A ^b  

^a Department of Pharmaceutical Sciences and Experimental Therapeutics   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM THIOSULFATE;

AREA UNDER THE CURVE; ARTICLE; CALCINOSIS; CALCULATION; DRUG BLOOD LEVEL; HEMODIALYSIS; HUMAN; PREDICTION; SIMULATION;

CALCIPHYLAXIS; CHELATING AGENTS; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KIDNEY FAILURE, CHRONIC; MODELS, BIOLOGICAL; RENAL DIALYSIS; THIOSULFATES;

EID: 79957873669     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09671010     Document Type: Article

References (29)

1. Guerra G, Shah RC, Ross EA: Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: Case report. Nephrol Dial Transplant 20: 1260-1262, 2005
2. Farah M, Crawford RI, Levin A, Yan CC: Calciphylaxis in the current era: Emerging 'ironic' features. Nephrol Dial Transplant 1: 191-195, 2011
3. Schlieper G, Brandenburg V, Ketteler M, Floege J: Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol 5: 539-543, 2009
4. Raymond CB, Wazny LD: Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis. Am J Health Syst Pharm 65: 1419-1429, 2008
5. Hackett BC, McAleer MA, Sheehan G, Powell FC, O'Donnell BF: Calciphylaxis in a patient with normal renal function: Response to treatment with sodium thiosulfate. Clin Exp Dermatol 34: 39-42, 2009
6. Hayden MR, Goldsmith D, Sowers JR, Khanna R: Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate. Int Urol Nephrol 40: 443-451, 2008
7. Baker BL, Fitzgibbons CA, Buescher LS: Calciphylaxis responding to sodium thiosulfate therapy. Arch Dermatol 143: 269-270, 2007
8. Musso CG, Enz P, Vidal F, Gelman R, Di Giuseppe L, Bevione P, Garfi L, Galimberti R, Algranati L: Oral sodium thiosulfate solution as a secondary preventive treatment for calciphylaxis in dialysis patients. Saudi J Kidney Dis Transpl 19: 820-821, 2008
9. Cicone JS, Petronis JB, Embert CD, Spector DA: Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 43: 1104-1108, 2004
10. Mataic D, Bastani B: Intraperitoneal sodium thiosulfate for the treatment of calciphylaxis. Ren Fail 28: 361-363, 2006
11. Meissner M, Kaufmann R, Gille J: Sodium thiosulphate: A new way of treatment for calciphylaxis? Dermatology 214: 278-282, 2007
12. Hayden MR, Tyagi SC, Kolb L, Sowers JR, Khanna R: Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxiscalcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovasc Diabetol 4: 4, 2005
13. Hudson JQ, Comstock TJ, Feldman GM: Evaluation of an in vitro dialysis system to predict drug removal. Nephrol Dial Transplant 19: 400-405, 2004
14. Gilman A, Philips FS, Koelle ES: The renal clearance of thiosulfate with observations on its volume of distribution. Am J Physiol 146: 348-357, 1946
15. Newman EV, Gilman A, Philips FS: The renal clearance of thiosulfate in man. Bull Johns Hopkins Hosp 79: 229-242, 1946
16. Crawford B: Depression of the exogenous creatinine/inulin or thiosulfate clearance ratios in man by diodrast and p-aminohippuric acid. J Clin Invest 27: 171-175, 1948
17. Shea M, Koziol JA, Howell SB: Kinetics of sodium thiosulfate, a cisplatin neutralizer. Clin Pharmacol Ther 35: 419-425, 1984
18. Ivankovich AD, Braverman B, Stephens TS, Shulman M, Heyman HJ: Sodium thiosulfate disposition in humans: Relation to sodium nitroprusside toxicity. Anesthesiology 58: 11-17, 1983
19. Smye SW, Will EJ: A mathematical analysis of a two-compartment model of urea kinetics. Phys Med Biol 40: 2005-2014, 1995
20. Michaels AS: Operating parameters and performance criteria for hemodialyzers and other membrane-separation devices. Trans Am Soc Artif Intern Organs 12: 387-392, 1966
21. Schneditz D, Hafner-Giessauf H, Holzer H, Thomaseth K: Intracorporeal glucose disposal during hemodialysis after a standardized glucose load. ASAIO J 56: 204-209, 2010
22. Yatzidis H: Successful sodium thiosulphate treatment for recurrent calcium urolithiasis. Clin Nephrol 23: 63-67, 1985
23. Kyriakopoulos G, Kontogianni K: Sodium thiosulfate treatment of tumoral calcinosis in patients with end-stage renal disease. Ren Fail 12: 213-219, 1990
24. Lambiotte C, Blanchard J, Graff S: Thiosulphate clearance in pregnancy. J Clin Invest 29: 1207-1213, 1950
25. Brun C: Thiosulphate as a measure of the glomerular filtration rate in normal and diseased human kidneys. Acta Med Scand 234: 63-70, 1949
26. Blegen E, Orning K, Aas K: The renal clearance of thiosulfate in man. Scandinav J Clin Lab Invest 1: 102-108, 1949
27. Schneditz D, Platzer D, Daugirdas JT: A diffusion-adjusted regional blood flow model to predict solute kinetics during haemodialysis. Nephrol Dial Transplant 24: 2218-2224, 2009
28. Eloot S, Torremans A, De Smet R Marescau B, De Wachter D, De Deyn PP, Lameire N, Verdonck P, Vanholder R: Kinetic behavior of urea is different from that of other watersoluble compounds: The case of the guanidino compounds. Kidney Int 67: 1566-1575, 2005
29. Eloot S, Torremans A, De Smet R, Marescau B, De Deyn PP, Verdonck P, Vanholder R: Complex compartmental behavior of small water-soluble uremic retention solutes: Evaluation by direct measurements in plasma and erythrocytes. Am J Kidney Dis 50: 279-288, 2007